• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceLIPOSORBER(R) LA-15 SYSTEM
Generic NameLipoprotein, low density, removal
ApplicantKANEKA PHARMA AMERICA CORP.
546 FIFTH AVE., 21ST FLOOR
NEW YORK, NY 10036
PMA NumberP910018
Supplement NumberS006
Date Received08/07/2000
Decision Date08/21/2000
Product Code MMY 
Advisory Committee Gastroenterology/Urology
Supplement Type30-Day Notice
Supplement Reason Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
CHANGE IN THE STERILIZATION PROCESS EQUIPMENT FOR THE PLASMAPHERESIS(R) LT-MA2 TUBING SYSTEM THAT IS USED WITH THE LIPOSORBER(R) LA-15 SYSTEM.
-
-